# @nyulangonehealth on YouTube

- **Type:** Video
- **Original URL:** https://youtube.com/watch?v=xUV0eKlDJcY
- **Gondola URL:** https://gondola.cc/posts/27483348-nyulangonehealth-youtube
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/1f6eeca357.jpg
- **Posted:** 2025-03-06T14:58:18.000+00:00
- **Account Owner:** NYU Langone Health (@nyulangone) — https://gondola.cc/nyulangone

## Caption

A new @NYULangone study finds GLP-1 agonists (Ozempic, Wegovy & more) cut the risk of organ failure by 49% & lower mortality by 31% for kidney transplant recipients with type 2 diabetes—though careful eye health monitoring is key. #Ozempic #mounjaro #kidneytransplantrecipient 

Learn more: https://nyulangone.org/doctors/1043483191/babak-j-orandi/appointment/new-patient/10017001

## Stats

- **Views:** 262
- **Likes:** 9
- **Shares:** 0
- **Comments:** 0

## Tags

kidneytransplantrecipient, ozempic, mounjaro

---
Copyright (c) Gondola